Issue 46, 2025

Spectroscopic investigations of a pharmaceutical solid form analogue: pyrimethanil l-tartaric acid hemi-cocrystal

Abstract

An approach towards pharmaceutical cocrystal analysis is reported for a model cocrystal system of pyrimethanil (an anilinopyrimidine fungicide) and L-tartaric acid (PYL-LTA-CC). Single crystal diffraction studies (X-ray and neutron) show PYL-LTA-CC to crystallise in the primitive orthorhombic space group P21212, with the asymmetric unit (1 : 0.5 stoichiometry) comprising two symmetry independent heterosynthons of pyrimethanil and a half tartaric acid fragment. The neutron diffraction study provides details of the hydrogen bonding in the two adducts and indicates that they are linked by N–H⋯O and N⋯H⋯O hydrogen bonds. Periodic-density functional theory calculations inform on the vibrational properties of PYL-LTA-CC, with the ab initio treatment validated by agreement between simulated and experimental inelastic neutron scattering spectra. Fourier transform infrared spectroscopy in attenuated total reflection mode (FTIR-ATR) and Fourier-transform Raman spectroscopy are used to probe the cocrystal's vibrational transitions. Notable deviations between computed and experimental infrared features are observed at higher wavenumbers, reflecting anharmonic contributions within the hydrogen-bonded network. Although most of the vibrational modes in the FTIR-ATR spectrum provide little direct information on the key hydrogen bonding interactions, a set of deformation modes in the range 1668–1618 cm−1 are diagnostic of distinct hydrogen bonding interactions within the asymmetric unit. The suitability of Raman spectroscopy for identifying hydrogen bonding is also examined, this technique being less information-rich than FTIR-ATR. Collectively, the study demonstrates how vibrational spectroscopy could be used to supplement investigations on the structure and form of the cocrystal as a potential drug delivery vector for this fungicide.

Graphical abstract: Spectroscopic investigations of a pharmaceutical solid form analogue: pyrimethanil l-tartaric acid hemi-cocrystal

Supplementary files

Article information

Article type
Paper
Submitted
23 Jul 2025
Accepted
05 Nov 2025
First published
06 Nov 2025
This article is Open Access
Creative Commons BY license

Phys. Chem. Chem. Phys., 2025,27, 24766-24776

Spectroscopic investigations of a pharmaceutical solid form analogue: pyrimethanil L-tartaric acid hemi-cocrystal

R. S. Dosanjh, A. Patterson, J. Harris, C. Wilson, M. J. Gutmann, P. Collier, T. Johnson, T. Hyde, A. P. E. York, S. F. Parker and D. Lennon, Phys. Chem. Chem. Phys., 2025, 27, 24766 DOI: 10.1039/D5CP02802G

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements